Paul Eckburg

Chief Medical Officer, AN2 Therapeutics, Inc.

Companies

AN2 Therapeutics, Inc.Chief Medical Officer Mar 24, 2022 to Mar 29, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

AN2 Therapeutics, Inc. ANTX51,416 shares²$168.1K at $3.27Mar 15, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 15, 2024Granted 30,000 shares of AN2 Therapeutics, Inc.²
Mar 15, 2024Granted 30,000 shares of AN2 Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAN2 Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARAN2 Therapeutics, Inc. shares after the filing of Mar 15, 2024
3
SEC EDGARForm 4 filed Mar 18, 2024